Intractable eczema

Intractable eczema refers to a severe, treatment-resistant clinical state of chronic eczematous dermatosis—most commonly atopic dermatitis—that fails to respond adequately to standard topical therapies, such as high-potency corticosteroids or calcineurin inhibitors, and routine trigger-avoidance measures

Intractable eczema refers to a severe, treatment-resistant clinical state of chronic eczematous dermatosis—most commonly atopic dermatitis—that fails to respond adequately to standard topical therapies, such as high-potency corticosteroids or calcineurin inhibitors, and routine trigger-avoidance measures Affecting the cutaneous system across pediatric and adult populations, it is pathophysiologically driven by persistent immune dysregulation, epidermal barrier dysfunction, and heightened neuroim...

Intractable eczema refers to a severe, treatment-resistant clinical state of chronic eczematous dermatosis—most commonly atopic dermatitis—that fails to respond adequately to standard topical therapies, such as high-potency corticosteroids or calcineurin inhibitors, and routine trigger-avoidance measures

Affecting the cutaneous system across pediatric and adult populations, it is pathophysiologically driven by persistent immune dysregulation, epidermal barrier dysfunction, and heightened neuroimmune signaling Clinically, it is characterized by relentless, debilitating pruritus, extensive xerosis, recurrent erythema, oozing, and lichenification, frequently complicated by secondary cutaneous infections and significant quality-of-life impairment

Affecting the cutaneous system across pediatric and adult populations, it is pathophysiologically driven by persistent immune dysregulation, epidermal barrier dysfunction, and heightened neuroimmune signaling

Clinically, it is characterized by relentless, debilitating pruritus, extensive xerosis, recurrent erythema, oozing, and lichenification, frequently complicated by secondary cutaneous infections and significant quality-of-life impairment